Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Iovance Biotherapeutics Inc. buy The Goldman Sachs Group, Inc.

Iovance Biotherapeutics Inc.
Start price
€1.71
12.05.25 / 50%
Target price
€7.13
12.05.26
Performance (%)
77.09%
End price
€3.03
13.05.26
Summary
This prediction ended on 13.05.26 with a price of €3.03. The BUY prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc. saw massive gains of 77.09%. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Iovance Biotherapeutics Inc. 17.667% 17.667% 206.661%
iShares Core DAX® -1.059% 5.007% 6.596%
iShares Nasdaq 100 -2.387% 0.864% 25.791%
iShares Nikkei 225® -4.361% 1.211% 41.309%
iShares S&P 500 -1.778% 1.391% 21.037%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Iovance Biotherapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 77.09%
Target price 7.126
Change
Ends at 12.05.26

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
12.05.25
In the thread Trading Iovance Biotherapeutics Inc.
Prediction Buy
Perf. (%) 77.09%
Target price 7.126
Change
Ends at 12.05.26

Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten

The Goldman Sachs Group, Inc. 
0
Report Share
13.05.26

Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.

sell
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.60
15.07.25
€0.86
15.07.26
152.63%
16.07.26

The Goldman Sachs Group, Inc. 
15.07.25 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€2.71
17.04.25
€14.08
17.04.26
17.73%
18.04.26

The Goldman Sachs Group, Inc. 
17.04.25 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€3.90
03.03.25
€18.11
03.03.26
-19.04%
04.03.26

The Goldman Sachs Group, Inc. 
03.03.25 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€14.52
29.02.24
€19.38
28.02.25
-72.27%
01.03.25

The Goldman Sachs Group, Inc. 
29.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€17.55
20.02.25
-53.22%
21.02.25

The Goldman Sachs Group, Inc. 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.05
20.11.23
€10.98
20.11.24
53.15%
21.11.24

The Goldman Sachs Group, Inc. 
20.11.23 50%